Physeon Receives Institutional Review Board Approval to Commence US "VIVA" Trial for Veinplicity
October 29, 2018 08:00 ET
|
Physeon
Recent Clinical Study Indicated Device had a Dilatory Effect 38% Greater than other Common Approaches for Veins Targeted for IV Access. Other studies indicate a First IV Stick Success Much Greater...